Category: St. Jude MedicalSyndicate content

St. Jude Medical's adjusted profit rises

October 15, 2014 by MassDevice

St. Jude Medical's adjusted profits rise during the 3rd quarter as the company narrows its earnings guidance and lowers its sales outlook.

St. Jude Medical's adjusted profit rises

Analyst says BSX may take CRM lead | Medtech Wall Street news for the week of September 29, 2014

October 2, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Boston Scientific could take CRM lead; Orthofix CFO bails after 6 months amid deepening financial fix; Fourth time's the charm: pSivida, Alimera jump on FDA nod for Iluvien; Echo Therapeutics is on the ropes; Activist investor erupts at Volcano

Analyst: Boston Scientific could take CRM lead

September 25, 2014 by Alexander Soule

BSX loses $309M judgment in patent war with the family of Dr. Michel Mirowski | Medtech legal news for the week of September 29, 2014

September 29, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Boston Scientific loses $309 million judgment in Mirowski patent war; Ex-Advanced Medical Optics CEO Mazzo indicted in insider trading case; Appeals court denies BD bid to revisit loss to Retractable Technologies; Ackman threatens to sue Allergan again over potential Salix deal; Judge upholds $30M infringement ruling against NuVasive, cancels trademark

Boston Scientific loses $309 million judgment in Mirowski patent war

September 24, 2014 by Brad Perriello

Analyst: Boston Scientific could take CRM lead

September 25, 2014 by Alex Soule

Despite Boston Scientific having yet to debut a pacemaker that nestles inside the heart itself, an analyst said the company may be best positioned to capitalize on sales of such devices.

Analyst: Boston Scientific could take pacer lead

Boston Scientific loses $309 million judgment in Mirowski patent war

September 24, 2014 by Brad Perriello

Boston Scientific loses a $309 million judgment in its long-running patent war with Mirowski Family ventures over cardiac pacemaker technology.

Boston Scientific loses $309 million judgment in Mirowski patent war

UPDATED Sept. 25, 2014, with comment from Boston Scientific.

St. Jude chases MRI-friendly labeling for its CRM devices

September 22, 2014 by Arezu Sarvestani

St. Jude Medical lands European approval to market its Tendril STS and IsoFlex Optim leads as safe for MRI scanning, adding that the company's just getting started on a larger MRI-safe campaign.

E.U. regulators dub St. Jude's Tendril STS, IsoFlex Optim leads safe with MRI